MCKESSON TO GROW US DISTRIBUTION NETWORK FOR MUTE
August 1, 2016. Melbourne, Australia.
Australian respiratory technology company Rhinomed (ASX:RNO) is pleased to announce the further expansion of its US distribution network through the appointment of McKesson Corporation as a wholesale distributor of the Mute snoring and sleep technology in the North American pharmacy market.
McKesson is one of the oldest and largest healthcare distribution companies in the world and is the fourth largest pharmacy network in the US. The appointment of McKesson is another major milestone in Rhinomed’s US distribution strategy.
McKesson service over 3000 pharmacies throughout the USA. The first pharmacy chain to stock Mute through McKesson’s network is Bartell Drugs. Bartell’s is a 64 store chain located in and around Seattle in Washington State, USA. It has been in operation since 1890 and has become an iconic part of the Seattle regional community.
McKesson serves more than 50% of American hospitals, 20% of US physicians and 96% of the top 25 health plans2 . The company delivers one-third of all the medications used throughout the US daily. McKesson is the world’s 11th largest company by revenues (USD179B in revenue in 2015) and is also the largest healthcare distribution company in the world.
Mute is an over-the-counter product to enable snorers to breathe more easily through their nose and help keep their mouth closed during sleep. Mute is designed to fit the natural anatomy of the nose and is individually adjustable on both sides so you can control the level of dilation and airflow.
The combined reach of these groups into the broader healthcare network of hospitals, professional services and healthcare plans fits with Rhinomed’s multi-channel strategy for Mute.